Lab Results

Should I Worry About My CRP Result?: A Functional-Medicine Interpretation Guide

Your lab report says your CRP is 'normal' — but functional-medicine practitioners often flag levels that standard reference ranges wave through. C-reactive protein is one of the most actionable inflammatory biomarkers available, yet most patients leave their doctor's office without understanding what it actually means. Here's how to read your CRP result the way a clinician would — and what to do when the number isn't where you want it.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·8 min read
CRPinflammationbiomarkerscardiovascular riskfunctional medicinehs-CRP
Should I Worry About My CRP Result?: A Functional-Medicine Interpretation Guide

What Is CRP and Why Does It Matter?

C-reactive protein (CRP) is a pentameric protein produced by the liver in response to inflammatory cytokines — primarily interleukin-6 (IL-6). It rises within hours of an acute insult (infection, injury, surgery) and falls just as quickly when the trigger resolves. That acute response is healthy. The problem is chronic low-grade elevation, which has been linked to cardiovascular disease, metabolic dysfunction, accelerated aging, and all-cause mortality across dozens of large epidemiological studies.

There are two CRP tests you may encounter:

  • Standard CRP — measures levels in milligrams per deciliter (mg/dL); useful for detecting active infection or acute inflammation. Reference range is typically < 1.0 mg/dL (< 10 mg/L).
  • High-sensitivity CRP (hs-CRP) — measures the same protein but at much lower concentrations, in mg/L; the relevant test for cardiovascular and metabolic risk stratification.

For most people asking "should I worry about my CRP result?", the answer depends almost entirely on which test was ordered and what the number actually is.

Understanding CRP Reference Ranges vs. Functional Optimal Ranges

Conventional labs flag hs-CRP as abnormal only above 10 mg/L — a threshold designed to catch acute illness. Functional medicine practitioners and cardiologists use a completely different lens.

The American Heart Association and U.S. Centers for Disease Control jointly published risk categories for hs-CRP that most functional clinicians adopt as a baseline framework (Ridker, Circulation 2003; PMID: 12551853):

hs-CRP Level (mg/L)Conventional LabelCardiovascular Risk CategoryFunctional-Medicine View
< 1.0NormalLowOptimal
1.0 – 3.0NormalAverageBorderline — investigate root cause
3.0 – 10.0Borderline highHighClinically significant; intervene
> 10.0ElevatedVery high / acuteRule out infection first, then address

The landmark JUPITER trial — which enrolled 17,802 apparently healthy men and women with LDL below 130 mg/dL — showed that participants with hs-CRP ≥ 2.0 mg/L had significantly elevated cardiovascular event risk even when their cholesterol looked fine (Ridker et al., New England Journal of Medicine 2008; PMID: 18997196). That finding shifted the conversation: CRP isn't just a backup biomarker. It's a primary risk signal in its own right.

A functional-medicine practitioner's optimal target is typically hs-CRP < 1.0 mg/L. Values between 1.0 and 3.0 mg/L are a yellow flag — worth investigating root causes such as poor sleep, visceral adiposity, periodontal disease, gut dysbiosis, or subclinical thyroid dysfunction, even if your doctor says "you're fine."

What Drives CRP Up — and What Lowers It

Before panicking over a single number, it's worth knowing that CRP is highly responsive to transient factors:

  • Recent illness, dental work, or injury can spike hs-CRP into the 10–40 mg/L range temporarily.
  • Intense exercise within 48 hours can elevate it mildly.
  • Pregnancy elevates baseline CRP throughout gestation.

If your result is unexpectedly high, re-testing in 2–3 weeks after ruling out acute illness is reasonable clinical practice.

For chronically elevated CRP (consistently > 2.0 mg/L), the evidence-backed levers include:

  1. Omega-3 fatty acids (EPA/DHA) — A meta-analysis of 68 randomized controlled trials (n > 4,400) found that omega-3 supplementation significantly reduced hs-CRP, with the largest effects seen at doses of 2–4 g/day of combined EPA+DHA (Calder et al., British Journal of Nutrition 2012; PMID: 22571826).
  2. Weight loss — Even modest reductions in visceral fat meaningfully lower IL-6 and downstream CRP.
  3. Mediterranean or anti-inflammatory dietary patterns — Associated with hs-CRP reductions of 20–30% in intervention studies.
  4. Curcumin — A meta-analysis of 15 RCTs found that curcumin supplementation significantly reduced both CRP and IL-6 (Sahebkar et al., Pharmacological Research 2016; PMID: 26775004).
  5. Addressing sleep — Even one night of sleep deprivation is sufficient to elevate CRP the following morning in experimental models.
  6. Treating underlying drivers — Insulin resistance, autoimmune activity, SIBO, and subclinical infections all feed chronic CRP elevation.

Notably, a number of these interventions are modifiable through targeted supplementation — but the key is identifying why your CRP is elevated before reaching for a product.

Should I Worry About My Homocysteine Result?

CRP rarely travels alone on an integrative blood panel. Homocysteine is another inflammatory biomarker frequently ordered alongside it, and one that's just as commonly misread.

Homocysteine is a sulfur-containing amino acid that accumulates when methylation pathways are impaired — typically due to deficiencies in B12, folate, or B6, or due to MTHFR gene variants that reduce folate metabolism efficiency. Elevated homocysteine damages vascular endothelium through oxidative stress, and the combination of high homocysteine and elevated CRP creates a multiplicative cardiovascular risk profile.

Conventional lab normal: < 15 µmol/L. Functional optimal: < 7–9 µmol/L.

A 2020 Cochrane review confirmed that B-vitamin supplementation reliably lowers homocysteine levels, though translation to hard cardiovascular endpoints depends on baseline risk and population studied (Cochrane Database of Systematic Reviews 2020). When your CRP is elevated alongside elevated homocysteine, the combined picture points strongly toward endothelial stress — and methylation support through methylated B-vitamins becomes a logical, evidence-backed intervention.

Should I Worry About My ESR Result?

Erythrocyte sedimentation rate (ESR) is often ordered alongside CRP in rheumatologic and inflammatory workups. Both measure inflammation, but through different mechanisms — and their divergence can be diagnostically useful.

CRP rises and falls within hours. ESR changes over days to weeks, reflecting the accumulation of fibrinogen and immunoglobulins that cause red blood cells to clump and fall faster in a tube. This means:

  • High CRP + High ESR → Active, ongoing systemic inflammation
  • High ESR + Normal CRP → Chronic or more indolent processes (myeloma, connective tissue disease, chronic infection)
  • High CRP + Normal ESR → Acute early-stage inflammation, bacterial infection

Functional reference range for ESR: < 10–15 mm/hr for men, < 20 mm/hr for women (age-adjusted). Standard labs allow considerably higher values, particularly in older adults, but practitioners looking at biological aging and vascular risk prefer lower targets.

If both your CRP and ESR are elevated, that's a meaningful signal worth investigating with a clinician — ruling out autoimmune disease, chronic infection, or malignancy is the appropriate first step before attributing the result to lifestyle factors alone.

Should I Worry About My Lp(a) Result?

Lipoprotein(a) — often written Lp(a) — is structurally similar to LDL but carries an additional apolipoprotein(a) particle that makes it particularly atherogenic. Unlike standard LDL, Lp(a) is largely genetically determined and isn't meaningfully lowered by diet or most lifestyle interventions. This makes it a critical biomarker to test early, particularly if you have a family history of premature cardiovascular disease.

Current cardiovascular guidelines from the European Society of Cardiology consider Lp(a) > 50 mg/dL (or > 125 nmol/L in molar units) a high-risk threshold. When Lp(a) is elevated alongside a chronically raised CRP, the combination signals a high inflammatory-atherosclerotic burden that warrants aggressive risk-factor management.

Niacin was historically used to lower Lp(a) by 20–30%, though its cardiovascular outcomes benefit in statin-treated patients has not been definitively proven. Emerging RNA-based therapies (e.g., pelacarsen) are showing promise in phase 3 trials, but these are prescription interventions. If your Lp(a) is > 50 mg/dL, prioritize a conversation with a cardiologist — this is one biomarker where supplementation alone is not the answer.

Should I Worry About My Triglycerides Result?

Triglycerides and CRP share a mechanistic relationship: elevated triglycerides signal metabolic inflammation, and the two biomarkers frequently co-elevate in insulin-resistant states. When your CRP is raised and your triglycerides are above 150 mg/dL, you're looking at a pattern consistent with metabolic syndrome — a cluster that substantially elevates cardiovascular and type 2 diabetes risk.

Functional optimal for triglycerides: < 100 mg/dL. Conventional normal is < 150 mg/dL.

Omega-3 fatty acids (EPA/DHA at 2–4 g/day) remain the most evidence-supported intervention for elevated triglycerides — FDA-approved prescription omega-3 formulations have demonstrated 20–45% triglyceride reductions in hypertriglyceridemia (Skulas-Ray et al., Circulation 2019; PMID: 31422671). For milder elevations, dietary carbohydrate reduction, resistance training, and weight loss consistently lower triglycerides alongside CRP — reinforcing that these two numbers often move together.

If your triglycerides are elevated and your CRP is borderline, treating the triglyceride pattern often resolves the CRP as a downstream effect.

What This Means for Your Formula

At Ones, uploaded lab results — including hs-CRP, homocysteine, triglycerides, and related inflammatory markers — feed directly into the AI health practitioner's analysis, which then maps your specific pattern to relevant ingredients from a curated catalog of clinically validated actives.

For CRP-relevant patterns, a few ingredients frequently emerge:

  • Omega-3 (EPA/DHA) — Ones sources pharmaceutical-grade omega-3 dosed at clinically meaningful levels (typically 1–2 g combined EPA+DHA per daily plan), consistent with the effect sizes demonstrated in the Calder et al. meta-analysis cited above. This is one of the most evidence-backed interventions for reducing hs-CRP and simultaneously addressing elevated triglycerides.
  • Curcumin — Included in formulas where the CRP pattern and inflammatory load support its use, at doses aligned with the intervention studies showing IL-6 and CRP reduction. The bioavailability-enhanced form matters here — Ones uses formulations designed for absorption, not standard curcumin powder.
  • Liver Support (System Blend) — CRP is produced by the liver, and hepatic dysfunction or fatty liver can sustain chronically elevated inflammatory output. When blood work suggests liver stress alongside elevated CRP, Ones may incorporate its proprietary Liver Support blend rather than isolated actives alone.

Because Ones formulas are calibrated to capsule budgets across a 6 or 9-capsule daily plan — selected by the AI based on your findings — the formula prioritizes the ingredients with the highest evidence-to-need ratio for your specific lab pattern, rather than stacking every available anti-inflammatory ingredient.

If you're interpreting your CRP alongside other inflammatory markers and want a data-driven approach to reducing them, you can learn more about how omega-3 dosing affects cardiovascular biomarkers and the role of anti-inflammatory nutrition on lab outcomes.

For those exploring related metabolic markers, our guides on understanding your triglycerides lab result and homocysteine and methylation support go deeper on each biomarker's clinical context.

Key Takeaways

  • The conventional CRP 'normal' range is not the same as the functional-medicine optimal. A result below 10 mg/L passes the standard lab filter but may still carry meaningful cardiovascular risk — functional practitioners target hs-CRP < 1.0 mg/L.
  • hs-CRP between 1.0 and 3.0 mg/L is a yellow flag, not a green light. It warrants investigation of root causes: sleep, visceral fat, gut health, blood sugar regulation, and thyroid function.
  • Omega-3 fatty acids (EPA/DHA) and curcumin are among the most evidence-backed supplements for reducing hs-CRP, with effect sizes documented in multiple RCTs and meta-analyses.
  • CRP does not exist in isolation — interpret it alongside homocysteine, ESR, Lp(a), and triglycerides for a complete inflammatory picture. Divergent patterns between these markers point toward different root causes.
  • A single elevated reading isn't diagnostic — re-test after ruling out acute illness, recent intense exercise, or dental work before concluding you have chronic inflammation.
  • Personalized supplementation based on your actual lab values — as offered through Ones — outperforms generic anti-inflammatory stacks, because the right dose of the right ingredient is only meaningful when the deficiency or dysfunction is confirmed.

Always consult a qualified healthcare provider before making changes to your supplementation protocol based on lab results. This article is for educational purposes and does not constitute medical advice.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Related reading